Scarica l'app Stockscreener
13.00
2.91%
0.30
Dopo l'orario di chiusura:
13.00
Precedente Chiudi:
$12.70
Aprire:
$12.5201
Volume 24 ore:
2,295
Relative Volume:
0.08
Capitalizzazione di mercato:
$62.88M
Reddito:
$2.61M
Utile/perdita netta:
$1.69M
Rapporto P/E:
43.29
EPS:
0.3003
Flusso di cassa netto:
-
1 W Prestazione:
+2.71%
1M Prestazione:
+14.32%
6M Prestazione:
+74.27%
1 anno Prestazione:
+45.22%
Intervallo 1D:
$12.52
$13.10
Intervallo di 1 settimana:
$12.52
$13.10
Portata 52W:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
Nome
Daxor Corporation
Settore
Industria
Telefono
212-330-8500
Indirizzo
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Confronta DXR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.00 | 63.95M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
434.62 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
185.29 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.09 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.39 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
267.19 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-05-16 | Iniziato | Ascendiant Capital Markets | Buy |
Daxor Corporation Borsa (DXR) Ultime notizie
Is Daxor Corporation stock a buy before product launches2025 Volatility Report & AI Driven Stock Movement Reports - newser.com
Chart overlay techniques for tracking Daxor CorporationJuly 2025 Movers & High Conviction Trade Alerts - newser.com
Using data filters to optimize entry into Daxor CorporationSwing Trade & Stock Market Timing Techniques - newser.com
Is Daxor Corporation stock poised for growthMarket Weekly Review & Weekly Top Stock Performers List - newser.com
Full technical analysis of Daxor Corporation stockDividend Hike & Weekly High Return Stock Forecasts - newser.com
Daxor (DXR) to Showcase at Cardiovascular Conference in Austin - GuruFocus
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference - TipRanks
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 - GlobeNewswire
Next‑Gen BVA System: Daxor Debuts Blood‑Volume Diagnostic at MedAxiom CV Transforum Oct 16–18 - Stock Titan
What earnings revisions data tells us about Daxor CorporationWeekly Profit Recap & Verified Trade Idea Suggestions - newser.com
Is Daxor Corporation reversing from oversold territoryMarket Volume Summary & AI Enhanced Trading Signals - newser.com
Using fundamentals and technicals on Daxor CorporationJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Can Daxor Corporation stock sustain free cash flow growthJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Will Daxor Corporation stock maintain dividend yieldJuly 2025 Patterns & Capital Efficiency Focused Ideas - newser.com
Can Daxor Corporation (DX5) stock retain market dominanceJuly 2025 Movers & Community Verified Swing Trade Signals - newser.com
Momentum divergence signals in Daxor Corporation chart2025 Market Overview & Risk Managed Trade Strategies - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyPortfolio Profit Report & Long-Term Growth Plans - newser.com
Will Daxor Corporation stock rally after Fed decisionsJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Daxor (NASDAQ:DXR) Given Hold (C-) Rating at Weiss Ratings - MarketBeat
What technical patterns form on Daxor Corporation (DX5) stock chartsRecession Risk & AI Forecast Swing Trade Picks - newser.com
Can momentum traders help lift Daxor CorporationPortfolio Update Report & AI Enhanced Execution Alerts - newser.com
Daxor (NYSEAMERICAN:DXR) Stock Price Passes Above Fifty Day Moving AverageHere's Why - MarketBeat
Can Daxor Corporation recover in the next quarterEntry Point & Long-Term Capital Growth Strategies - newser.com
Is Daxor Corporation meeting your algorithmic filter criteriaDollar Strength & Long-Term Capital Growth Strategies - newser.com
Daxor Corporation (NASDAQ:DXR) Short Interest Down 34.7% in September - MarketBeat
Maxim Group Maintains Daxor(DXR.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛
How to manage a losing position in Daxor CorporationWeekly Trade Report & Weekly Sector Rotation Insights - newser.com
Blood Volume, Reimagined: Daxor’s BVA Could Slash Testing Time and Save Lives - insights.citeline.com
Historical volatility pattern of Daxor Corporation visualizedQuarterly Market Review & Smart Allocation Stock Tips - newser.com
Technical analysis overview for Daxor Corporation stock2025 Biggest Moves & Weekly Momentum Stock Picks - newser.com
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA - GlobeNewswire
Daxor Corporation's BVA Technology Proven to Reduce Hospital Readmissions and Enhance Survival Rates in Heart Failure Patients - Quiver Quantitative
Zero Hospital Readmissions: Daxor's New Blood Volume Tech Shows Perfect Results in Heart Failure Study - Stock Titan
Daxor Corporation Azioni (DXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.08%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):